|
|
???tair.name??? >
???browser.page.title.author???
|
"徐士哲"???jsp.browse.items-by-author.description???
Showing items 1-10 of 45 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
| 修平科技大學 |
2019-11 |
太陽能泡泡機研究組裝
|
彭國誠;鍾旻村;周子為;徐士哲 |
| 臺大學術典藏 |
2018-09-10T09:47:01Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
林肇堂 ;陳美志 ;徐士哲 ;李宜家 ;王秀伯 ;李基裕 ;劉志銘 ;孫家棟 ;吳明賢 ;陳建全 ;方佑仁 ;陳介章 ;曾屏輝; 林肇堂;陳美志;徐士哲;李宜家;王秀伯;李基裕;劉志銘;孫家棟;吳明賢;陳建全;方佑仁;陳介章;曾屏輝; CHIH-HSIEN WANG; Liou, Jyh-Ming; Liou, Jyh-Ming; Liou, Jyh-Ming; PING-HUEI TSENG; Chen, Chieh-Chang; Chen, Chieh-Chang; Chen, Chieh-Chang; Chang, Chi-Yang; Chang, Chi-Yang; TSU-YAO CHENG; JYH-MING LIOU; Chen, Mei-Jyh; Chen, Mei-Jyh; Fang, Yu-Jen; Fang, Yu-Jen; YI-CHIA LEE; Lee, Ji-Yuh; Lee, Ji-Yuh; Lee, Ji-Yuh; LU-PING CHOW; Chen, Chien-Chuan; MING-SHIANG WU; Chen, Chien-Chuan; Chen, Chien-Chuan; CHIA-TUNG SHUN; Hsu, Shih-Jer; Hsu, Shih-Jer; Hsu, Shih-Jer; Hsu, Yao-Chun; Hsu, Yao-Chun; Tseng, Cheng-Hao; Tseng, Cheng-Hao; Tseng, Ping-Huei; Tseng, Ping-Huei; Chang, Lawrence; Chang, Lawrence; Chang, Lawrence; Chang, Wen-Hsiung; Chang, Wen-Hsiung; Chang, Wen-Hsiung; Wang, Hsiu-Po; Wang, Hsiu-Po; Shun, Chia-Tung; Shun, Chia-Tung; Shun, Chia-Tung; Wu, Jeng-Yih; Wu, Jeng-Yih; Lee, Yi-Chia; Lee, Yi-Chia; Lee, Yi-Chia; Lin, Jaw-Town; Lin, Jaw-Town; Lin, Jaw-Town; Wu, Ming-Shiang; Wu, Ming-Shiang; Wu, Ming-Shiang; Liou, Jyh-Ming;Chen, Chieh-Chang;Chang, Chi-Yang;Chen, Mei-Jyh;Fang, Yu-Jen;Lee, Ji-Yuh;Chen, Chien-Chuan;Hsu, Shih-Jer;Hsu, Yao-Chun;Tseng, Cheng-Hao;Tseng, Ping-Huei;Chang, Lawrence;Chang, Wen-Hsiung;Wang, Hsiu-Po;Shun, Chia-Tung;Wu, Jeng-Yih;Lee, Yi-Chia;Lin, Jaw-Town;Wu, Ming-Shiang; Liou, Jyh-Ming;Chen, Chieh-Chang;Chang, Chi-Yang;Chen, Mei-Jyh;Fang, Yu-Jen;Lee, Ji-Yuh;Chen, Chien-Chuan;Hsu, Shih-Jer;Hsu, Yao-Chun;Tseng, Cheng-Hao;Tseng, Ping-Huei;Chang, Lawrence;Chang, Wen-Hsiung;Wang, Hsiu-Po;Shun, Chia-Tung;Wu, Jeng-Yih;Lee, Yi-Chia;Lin, Jaw-Town;Wu, Ming-Shiang; Liou, Jyh-Ming;Chen, Chieh-Chang;Chang, Chi-Yang;Chen, Mei-Jyh;Fang, Yu-Jen;Lee, Ji-Yuh;Chen, Chien-Chuan;Hsu, Shih-Jer;Hsu, Yao-Chun;Tseng, Cheng-Hao;Tseng, Ping-Huei;Chang, Lawrence;Chang, Wen-Hsiung;Wang, Hsiu-Po;Shun, Chia-Tung;Wu, Jeng-Yih;Lee, Yi-Chia;Lin, Jaw-Town;Wu, Ming-Shiang; Liou, J.-M. and Chen, C.-C. and Chang, C.-Y. and Chen, M.-J. and Fang, Y.-J. and Lee, J.-Y. and Chen, C.-C. and Hsu, S.-J. and Hsu, Y.-C. and Tseng, C.-H. and Tseng, P.-H. and Chang, L. and Chang, W.-H. and Wang, H.-P. and Shun, C.-T. and Wu, J.-Y. and Lee, Y.-C. and Lin, J.-T. and Wu, M.-S. and Lin, C.-H. and Chow, L.-P. and Cheng, T.-Y. and Wu, C.-Y. and Lee Ching-Tai, C.-T and Wang, W.-L. and Tai, C.-M. and Wang, Y.-C. and Wang, C.-H. and Kuo, S.-H. and Wu, C.-Y. |
| 臺大學術典藏 |
2018-09-10T09:23:42Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU |
| 臺大學術典藏 |
2018-09-10T09:14:16Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen, C.-C. and Lee, J.-Y. and Fang, Y.-J. and Hsu, S.-J. and Han, M.-L. and Tseng, P.-H. and Liou, J.-M. and Hu, F.-C. and Lin, T.-L. and Wu, M.-S. and Wang, H.-P. and Lin, J.-T.; Chen, C. -C.;Lee, J. -Y.;Fang, Y. -J.;Hsu, S. -J.;Han, M. -I.;Tseng, P. -H.;Liou, J. -M.;Hu, F. -C.;Lin, T. -I.;Wu, M. -S.;Wang, H. -P.;Lin, J. -T.; Chen, C.-C.;Lee, J.-Y.;Fang, Y.-J.;Hsu, S.-J.;Han, M.-I.;Tseng, P.-H.;Liou, J.-M.;Hu, F.-C.;Lin, T.-I.;Wu, M.-S.;Wang, H.-P.;Lin, J.-T.; 林肇堂 ;徐士哲 ;王秀伯 ;李基裕 ;劉志銘 ;吳明賢 ;陳建全 ;方佑仁 ;陳介章 ;曾屏輝; 林肇堂;徐士哲;王秀伯;李基裕;劉志銘;吳明賢;陳建全;方佑仁;陳介章;曾屏輝; PING-HUEI TSENG; Chen, C.-C.; Chen, C. -C.; Lee, J. -Y.; Lee, J.-Y.; JYH-MING LIOU; Fang, Y.-J.; Fang, Y. -J.; MING-SHIANG WU; Hsu, S. -J.; Hsu, S.-J.; Han, M.-I.; Han, M. -I.; Tseng, P.-H.; Tseng, P. -H.; Liou, J. -M.; Liou, J.-M.; Hu, F. -C.; Hu, F.-C.; Lin, T.-I.; Lin, T. -I.; Wu, M. -S.; Wu, M.-S.; Wang, H. -P.; Wang, H.-P.; Lin, J.-T.; Lin, J. -T.; 王秀伯; 陳建全 |
| 國立臺灣大學 |
2016 |
Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Liu, Wei-Liang; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 徐士哲 |
| 國立臺灣大學 |
2016 |
HIGHER GENETIC BARRIER REVEALED IN HCV GT-1B/2/4/6 SUBJECTS THAN GT-1A PATIENTS - A PROOF OF CONCEPT TRIAL OF TG-2349 (FURAPREVIR)
|
Yeh, C. -T.; Hsu, S. -J.; Hu, T. -H.; Liu, C. -J.; Tsai, C. -E.; Chen, C. -M.; Chang, L. -W.; Lin, C. -C.; King, C. -H. R.; Hsu, M-C.; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2016 |
TG-2349, A POTENT PROTEASE INHIBITOR, PLUS PEGIFN/RBV PROVIDES EXCELLENT VIROLOGICAL RESPONSES FOR HARDER-TO-TREAT SUBPOPULATIONS OF HCV-1B NON-CIRRHOTIC PATIENTS
|
Yu, M. -L.; Hsu, S. -J.; Yeh, C. -T.; Hung, C. -H.; Chen, M. -Y.; Chen, P. -J.; Huang, Y. -H.; Cheng, P. -N.; Chen, C. -M.; Chang, L. -W.; Lin, C. -C.; Sheen, F.; King, C. -H. R.; Kuo, E.; Hsu, M. -C.; 徐士哲; 陳培哲 |
| 國立臺灣大學 |
2015 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
Showing items 1-10 of 45 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page
|
